16 Aug 2023 --- DSM-Firmenich has received “no-questions” response letters from the US FDA on its Generally Recognized as Safe (GRAS) notices for three new human milk oligosaccharide (HMO) ingredients, indicating that the ingredients are permitted for use on the US market.